VITASPRING BIOMEDICAL CO., LTD. Deferred Compensation Equity
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Deferred Compensation Equity of $290.41 thousand as of 2021-01-31, per its 10-K filed 2021-04-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2021-04-14
- 2021-01-31: Deferred Compensation Equity $290.41K.
| Period end | Deferred Compensation Equity |
|---|---|
| 2021-01-31 | $290.41K 10-K · filed 2021-04-14 |